62 related articles for article (PubMed ID: 9649146)
1. Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.
Atra A; Gerrard M; Hobson R; Imeson JD; Ashley S; Pinkerton CR
Br J Cancer; 1998 Jun; 77(12):2281-5. PubMed ID: 9649146
[TBL] [Abstract][Full Text] [Related]
2. Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children's Cancer Group Multicentre Trial, JPLSG B-NHL-20).
Sekimizu M; Fukano R; Koga Y; Mitsui T; Fujita N; Mori T; Hori D; Tanaka M; Ohki K; Iwafuchi H; Nakazawa A; Mori T; Kobayashi R; Hashimoto H; M Saito A; Kamei M;
BMJ Open; 2024 Mar; 14(3):e080762. PubMed ID: 38508620
[TBL] [Abstract][Full Text] [Related]
3. [The clinical characteristics and outcomes of 16 Burkitt' s lymphoma with testicular involvement].
Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Zhang YH
Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):768-773. PubMed ID: 27719719
[TBL] [Abstract][Full Text] [Related]
4. Optimal dosage of rituximab for children with Burkitt lymphoma.
Huang S; Jin L; Yang J; Zhang M; Zhang Y; Peng Y; Duan Y; Zheng H
Ann Hematol; 2024 Mar; 103(3):893-903. PubMed ID: 38091052
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcome in children with central nervous system-positive Burkitt lymphoma using only intrathecal and systemic chemotherapy combined with rituximab.
Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Zhang YH
Chin Med J (Engl); 2021 Mar; 134(11):1329-1334. PubMed ID: 33734131
[TBL] [Abstract][Full Text] [Related]
6. Early-stage Burkitt lymphoma remained in remission 7 years from diagnosis after only one cycle of chemoimmunotherapy.
Al Sbihi A; Manasrah N; Sano D; Lonardo S
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33879463
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of neuropathy during intensive vincristine chemotherapy for non-Hodgkin's lymphoma and Acute Lymphoblastic Leukemia.
Dorchin M; Masoumi Dehshiri R; Soleiman S; Manashi M
Iran J Ped Hematol Oncol; 2013; 3(4):138-42. PubMed ID: 24575286
[TBL] [Abstract][Full Text] [Related]
8. T-cell Lymphoblastic Lymphoma Presenting as a Pituitary Mass.
Sreedhara P; Czerwinski V; Alexander E; Choudhary C
JCEM Case Rep; 2023 Sep; 1(5):luad097. PubMed ID: 37908217
[TBL] [Abstract][Full Text] [Related]
9. Sinonasal Lymphoma Presenting as a Probable Sanctuary Site for Relapsed B Acute Lymphoblastic Leukaemia: A Case Report and Review of the Literature.
Lim WY; Care R; Lau M; Chiruka S; Dawes PJ
Case Rep Hematol; 2015; 2015():697957. PubMed ID: 26697242
[TBL] [Abstract][Full Text] [Related]
10. Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents.
Attarbaschi A; Carraro E; Ronceray L; Andrés M; Barzilai-Birenboim S; Bomken S; Brugières L; Burkhardt B; Ceppi F; Chiang AKS; Csoka M; Fedorova A; Jazbec J; Kabickova E; Loeffen J; Mellgren K; Miakova N; Moser O; Osumi T; Pourtsidis A; Rigaud C; Uyttebroeck A; Woessmann W; Pillon M;
Leukemia; 2021 Feb; 35(2):534-549. PubMed ID: 32393843
[TBL] [Abstract][Full Text] [Related]
11. Burkitt and Burkitt-Like Lymphomas: a Systematic Review.
Saleh K; Michot JM; Camara-Clayette V; Vassetsky Y; Ribrag V
Curr Oncol Rep; 2020 Mar; 22(4):33. PubMed ID: 32144513
[TBL] [Abstract][Full Text] [Related]
12. In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes.
Opie J; Antel K; Koller A; Novitzky N
Ann Hematol; 2020 Mar; 99(3):571-578. PubMed ID: 31955214
[TBL] [Abstract][Full Text] [Related]
13. Low-dose rasburicase in hematologic malignancies.
Jayabose S; Kumar V; Dhanabalan R; Rajan P; Rathnam K; Viswanathan TK
Indian J Pediatr; 2015 May; 82(5):458-61. PubMed ID: 25338496
[TBL] [Abstract][Full Text] [Related]
14. Acute visual loss as the initial presentation in a child with systemic Burkitt lymphoma.
Kourti M; Mantadakis E; Anastasiou A; Koliouskas D
Indian J Med Paediatr Oncol; 2013 Apr; 34(2):99-100. PubMed ID: 24049296
[TBL] [Abstract][Full Text] [Related]
15. Melatonin anticancer effects: review.
Di Bella G; Mascia F; Gualano L; Di Bella L
Int J Mol Sci; 2013 Jan; 14(2):2410-30. PubMed ID: 23348932
[TBL] [Abstract][Full Text] [Related]
16. Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia.
Crews KR; Zhou Y; Pauley JL; Howard SC; Jeha S; Relling MV; Pui CH
Cancer; 2010 Jan; 116(1):227-32. PubMed ID: 19834958
[TBL] [Abstract][Full Text] [Related]
17. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.
Cairo MS; Gerrard M; Sposto R; Auperin A; Pinkerton CR; Michon J; Weston C; Perkins SL; Raphael M; McCarthy K; Patte C;
Blood; 2007 Apr; 109(7):2736-43. PubMed ID: 17138821
[TBL] [Abstract][Full Text] [Related]
18. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
Patte C; Auperin A; Gerrard M; Michon J; Pinkerton R; Sposto R; Weston C; Raphael M; Perkins SL; McCarthy K; Cairo MS;
Blood; 2007 Apr; 109(7):2773-80. PubMed ID: 17132719
[TBL] [Abstract][Full Text] [Related]
19. Burkitt's and Burkitt-like lymphoma.
Evens AM; Gordon LI
Curr Treat Options Oncol; 2002 Aug; 3(4):291-305. PubMed ID: 12074766
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
